Home » Newsletters » BioWorld Science

BioWorld Science

May 2, 2005

View Archived Issues

DA-8159 as a treatment for diabetic erectile dysfunction

CC-4047's mechanism of action remains unclear

NexBio presents Fludase, a novel antiinfluenza recombinant fusion protein / News in Context

Two liposomal lurtotecan regimens induce antitumor effects in relapsed ovarian cancer

CEP-8983 chemosensitizes resistant cells and xenografts

BTS-2 inhibitory activity depends on redox state of tNOX

APF-530 enters phase II for CINV in cancer patients

ISTA seeks green light for phase III trial of combination ophthalmic product

ZLB Behring to study C1-INH concentrate for hereditary angioedema

Inspire reports ophthalmic programs update

Mitsubishi Chemical and Mitsubishi Pharma to form joint holding company

Phase I cancer study of CYT-997 set to begin in May

Prism to market Penwest's PW-2101 in U.S., Canada

Vical's bivalent CMV vaccine set for phase II

ISIS-369645 enters development for asthma

New treatments for cancer covered in recent patents

AS-1410 selected for phase I evaluation against cancer

Complete tumor regression in mice treated with huC242-DM4

First, highly selective 5-HT1D antagonist reported

Novel antihypertensive agents discovered at Bristol-Myers Squibb

Santarus reports new formulations of omeprazole for treating acid-induced gastrointestinal disorders

New antidiabetic agents from Ligand and Takeda

Phase I data confirm MVA-3000 vaccine is safe and immunogenic in healthy volunteers

Evidence suggests a link between sleep disorders and metabolic syndrome in mice

UNBS-1450 demonstrates in vitro and in vivo anticancer activity

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 12, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld Science
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...